Synopsis
Synopsis
0
USDMF
0
JDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Clopidogrel
2. Clopidogrel Besilate
3. Clopidogrel Bisulfate
4. Clopidogrel Hydrochloride
5. Clopidogrel Mepha
6. Clopidogrel Napadisilate
7. Clopidogrel Sandoz
8. Clopidogrel, (+)(s)-isomer
9. Clopidogrel-mepha
10. Iscover
11. Pcr 4099
12. Pcr-4099
13. Plavix
14. Sc 25989c
15. Sc 25990c
16. Sr 25989
1. Clopidogrel Besilate
2. 744256-69-7
3. Bl9vgg8bhw
4. Clopidogrel Benzenesulfonic Acid Salt
5. Clopidogrel Benzenesulfonate
6. (s)-methyl-2-(2-chlorophenyl)-2-(6,7-dihydrothieno(3,2-c)pyridin-5(4h)-yl)acetate Methanesulfonate
7. Benzenesulfonic Acid;methyl (2s)-2-(2-chlorophenyl)-2-(6,7-dihydro-4h-thieno[3,2-c]pyridin-5-yl)acetate
8. (s)-methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4h)-yl)acetate Benzenesulfonate
9. Thieno(3,2-c)pyridine-5(4h)-acetic Acid, Alpha-(2-chlorophenyl)-6,7-dihydro-, Methyl Ester, (alphas)-, Benzenesulfonate (1:1)
10. Thieno[3,2-c]pyridine-5(4h)-acetic Acid, Alpha-(2-chlorophenyl)-6,7-dihydro-, Methyl Ester, (alphas)-, Benzenesulfonate (1:1)
11. Unii-bl9vgg8bhw
12. Grepid
13. Schembl365641
14. Clopidogrel Acino Pharma
15. Dtxsid30225441
16. Clopidogrel Acino Pharma Gmbh
17. Clopidogrel Besylate [who-dd]
18. Akos026751491
19. Clopidogrel Besilate [ema Epar]
20. Thieno(3,2-c)pyridine-5(4h)-acetic Acid, Alpha-(2-chlorophenyl)-6,7-dihydro-, Methyl Ester, (alphas)-, Benzenesulfonate
21. Clopidogrel Besilate [ep Monograph]
22. D10824
23. Q27274743
24. Thieno(3,2-c)pyridine-5(4h)-acetic Acid, .alpha.-(2-chlorophenyl)-6,7-dihydro-, Methyl Ester, (.alpha.s)-, Benzenesulfonate
25. Thieno(3,2-c)pyridine-5(4h)-acetic Acid, .alpha.-(2-chlorophenyl)-6,7-dihydro-, Methyl Ester, (.alpha.s)-, Benzenesulfonate (1:1)
| Molecular Weight | 480.0 g/mol |
|---|---|
| Molecular Formula | C22H22ClNO5S2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | 479.0627928 g/mol |
| Monoisotopic Mass | 479.0627928 g/mol |
| Topological Polar Surface Area | 121 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 565 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)
Purinergic P2Y Receptor Antagonists
Compounds that bind to and block the stimulation of PURINERGIC P2Y RECEPTORS. Included under this heading are antagonists for specific P2Y receptor subtypes. (See all compounds classified as Purinergic P2Y Receptor Antagonists.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
A Clopidogrel Besylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clopidogrel Besylate, including repackagers and relabelers. The FDA regulates Clopidogrel Besylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clopidogrel Besylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clopidogrel Besylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clopidogrel Besylate supplier is an individual or a company that provides Clopidogrel Besylate active pharmaceutical ingredient (API) or Clopidogrel Besylate finished formulations upon request. The Clopidogrel Besylate suppliers may include Clopidogrel Besylate API manufacturers, exporters, distributors and traders.
click here to find a list of Clopidogrel Besylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Clopidogrel Besylate Drug Master File in Korea (Clopidogrel Besylate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clopidogrel Besylate. The MFDS reviews the Clopidogrel Besylate KDMF as part of the drug registration process and uses the information provided in the Clopidogrel Besylate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Clopidogrel Besylate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clopidogrel Besylate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Clopidogrel Besylate suppliers with KDMF on PharmaCompass.
A Clopidogrel Besylate CEP of the European Pharmacopoeia monograph is often referred to as a Clopidogrel Besylate Certificate of Suitability (COS). The purpose of a Clopidogrel Besylate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Clopidogrel Besylate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Clopidogrel Besylate to their clients by showing that a Clopidogrel Besylate CEP has been issued for it. The manufacturer submits a Clopidogrel Besylate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Clopidogrel Besylate CEP holder for the record. Additionally, the data presented in the Clopidogrel Besylate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Clopidogrel Besylate DMF.
A Clopidogrel Besylate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Clopidogrel Besylate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Clopidogrel Besylate suppliers with CEP (COS) on PharmaCompass.
A Clopidogrel Besylate written confirmation (Clopidogrel Besylate WC) is an official document issued by a regulatory agency to a Clopidogrel Besylate manufacturer, verifying that the manufacturing facility of a Clopidogrel Besylate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Clopidogrel Besylate APIs or Clopidogrel Besylate finished pharmaceutical products to another nation, regulatory agencies frequently require a Clopidogrel Besylate WC (written confirmation) as part of the regulatory process.
click here to find a list of Clopidogrel Besylate suppliers with Written Confirmation (WC) on PharmaCompass.
Clopidogrel Besylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clopidogrel Besylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clopidogrel Besylate GMP manufacturer or Clopidogrel Besylate GMP API supplier for your needs.
A Clopidogrel Besylate CoA (Certificate of Analysis) is a formal document that attests to Clopidogrel Besylate's compliance with Clopidogrel Besylate specifications and serves as a tool for batch-level quality control.
Clopidogrel Besylate CoA mostly includes findings from lab analyses of a specific batch. For each Clopidogrel Besylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clopidogrel Besylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Clopidogrel Besylate EP), Clopidogrel Besylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clopidogrel Besylate USP).
LOOKING FOR A SUPPLIER?
